Xponance Inc. Decreases Position in HCA Healthcare, Inc. $HCA

Xponance Inc. lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,067 shares of the company’s stock after selling 1,833 shares during the quarter. Xponance Inc.’s holdings in HCA Healthcare were worth $15,798,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $1,021,000. NewEdge Advisors LLC grew its position in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its position in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of HCA Healthcare by 1.5% in the 2nd quarter. Bessemer Group Inc. now owns 2,828 shares of the company’s stock worth $1,084,000 after acquiring an additional 42 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at about $2,943,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.5%

Shares of NYSE HCA opened at $528.69 on Friday. The stock has a market cap of $118.23 billion, a P/E ratio of 18.63, a PEG ratio of 1.62 and a beta of 1.36. The business’s fifty day simple moving average is $493.99 and its 200-day simple moving average is $459.94. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $552.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the previous year, the company posted $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent analyst reports. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a report on Monday, February 9th. Leerink Partners upped their price target on HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Royal Bank Of Canada upped their target price on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Cantor Fitzgerald raised their price target on HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $534.50.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 15,214 shares of company stock worth $7,797,595. Insiders own 1.30% of the company’s stock.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.